JP2012516881A5 - - Google Patents

Download PDF

Info

Publication number
JP2012516881A5
JP2012516881A5 JP2011548754A JP2011548754A JP2012516881A5 JP 2012516881 A5 JP2012516881 A5 JP 2012516881A5 JP 2011548754 A JP2011548754 A JP 2011548754A JP 2011548754 A JP2011548754 A JP 2011548754A JP 2012516881 A5 JP2012516881 A5 JP 2012516881A5
Authority
JP
Japan
Prior art keywords
ylmethyl
azaspiro
carbamate
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011548754A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012516881A (ja
JP5586632B2 (ja
Filing date
Publication date
Priority claimed from FR0900493A external-priority patent/FR2941696B1/fr
Application filed filed Critical
Publication of JP2012516881A publication Critical patent/JP2012516881A/ja
Publication of JP2012516881A5 publication Critical patent/JP2012516881A5/ja
Application granted granted Critical
Publication of JP5586632B2 publication Critical patent/JP5586632B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011548754A 2009-02-05 2010-02-04 5員の複素環式化合物のアザスピラニル−アルキルカルバメートの誘導体、この調製およびこの治療的使用 Expired - Fee Related JP5586632B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0900493A FR2941696B1 (fr) 2009-02-05 2009-02-05 Derives d'azaspiranyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR0900493 2009-02-05
PCT/FR2010/050183 WO2010089510A2 (fr) 2009-02-05 2010-02-04 Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique

Publications (3)

Publication Number Publication Date
JP2012516881A JP2012516881A (ja) 2012-07-26
JP2012516881A5 true JP2012516881A5 (cg-RX-API-DMAC10.html) 2014-07-17
JP5586632B2 JP5586632B2 (ja) 2014-09-10

Family

ID=41037747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011548754A Expired - Fee Related JP5586632B2 (ja) 2009-02-05 2010-02-04 5員の複素環式化合物のアザスピラニル−アルキルカルバメートの誘導体、この調製およびこの治療的使用

Country Status (20)

Country Link
US (1) US8889702B2 (cg-RX-API-DMAC10.html)
EP (1) EP2393809B1 (cg-RX-API-DMAC10.html)
JP (1) JP5586632B2 (cg-RX-API-DMAC10.html)
KR (1) KR20110117215A (cg-RX-API-DMAC10.html)
CN (1) CN102369200B (cg-RX-API-DMAC10.html)
AR (1) AR075247A1 (cg-RX-API-DMAC10.html)
AU (1) AU2010212235B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI1007456A2 (cg-RX-API-DMAC10.html)
CA (1) CA2751481C (cg-RX-API-DMAC10.html)
CO (1) CO6362007A2 (cg-RX-API-DMAC10.html)
EA (1) EA201171000A1 (cg-RX-API-DMAC10.html)
FR (1) FR2941696B1 (cg-RX-API-DMAC10.html)
IL (1) IL214390A0 (cg-RX-API-DMAC10.html)
MA (1) MA33104B1 (cg-RX-API-DMAC10.html)
MX (1) MX2011008308A (cg-RX-API-DMAC10.html)
SG (1) SG173557A1 (cg-RX-API-DMAC10.html)
TN (1) TN2011000331A1 (cg-RX-API-DMAC10.html)
TW (1) TW201039823A (cg-RX-API-DMAC10.html)
UY (1) UY32423A (cg-RX-API-DMAC10.html)
WO (1) WO2010089510A2 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130150346A1 (en) 2010-01-08 2013-06-13 Quest Ventures Ltd. Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
WO2011123719A2 (en) 2010-03-31 2011-10-06 Ironwood Pharmaceuticals, Inc. Use of faah inhibitors for treating abdominal, visceral and pelvic pain
HRP20170411T1 (hr) 2012-03-02 2017-06-16 Genentech, Inc. Amido spirocilični amidni i sulfonamidni derivati
JP6099753B2 (ja) * 2012-10-03 2017-03-22 アドビナス セラピューティクス リミテッド スピロ環化合物、その組成物及びその医薬応用
ES2699351T3 (es) 2014-01-17 2019-02-08 Novartis Ag Derivados de 1-piridazin/triazin-3-il-piper(-azina)/idina/pirolidina y composiciones de las mismas para inhibir la actividad de SHP2
JO3517B1 (ar) 2014-01-17 2020-07-05 Novartis Ag ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
WO2015107494A1 (en) 2014-01-17 2015-07-23 Novartis Ag 1 -(triazin-3-yi_/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2
ES2824576T3 (es) 2015-06-19 2021-05-12 Novartis Ag Compuestos y composiciones para inhibir la actividad de SHP2
EP3310779B1 (en) 2015-06-19 2019-05-08 Novartis AG Compounds and compositions for inhibiting the activity of shp2
WO2016203406A1 (en) 2015-06-19 2016-12-22 Novartis Ag Compounds and compositions for inhibiting the activity of shp2
WO2017160925A1 (en) * 2016-03-16 2017-09-21 Kalyra Pharmaceuticals, Inc. Analgesic compounds
PT3468972T (pt) 2016-06-14 2020-08-21 Novartis Ag Compostos e composições para inibir a atividade da shp2
JOP20190107A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
CN110730678B (zh) 2017-01-10 2022-07-15 诺华股份有限公司 包含alk抑制剂和shp2抑制剂的药物组合
PT3595665T (pt) 2017-03-13 2024-11-21 Lundbeck La Jolla Research Center Inc Inibidores duplos de magl e faah
UA126685C2 (uk) 2017-08-29 2023-01-11 Луннбек Ла-Холья Рісьоч Сенте, Інк. Сполуки, які є модуляторами magl, і способи їх отримання і застосування
TWI731420B (zh) * 2018-09-27 2021-06-21 大陸商深圳微芯生物科技股份有限公司 具有吲哚胺-2,3-雙加氧酶抑制活性的喹啉衍生物及其製備方法、藥物組合物、聯合用藥物與用途
WO2023213854A1 (en) 2022-05-04 2023-11-09 H. Lundbeck A/S Crystalline form of 1,1,1,3,3,3-hexafluoropropan-2-yl (s)-1-(pyridazin-3-ylcarbamoyl)-6 azaspiro[2.5]octane-6-carboxylate as monoacylglycerol lipase inhibitor.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2111463C (en) 1991-06-19 1997-08-26 Bingwei V. Yang Azaspiro quinolone antibacterial agents
CA2262569A1 (en) 1996-08-09 1998-02-19 Norihito Ohi Benzopiperidine derivatives
RU2229476C2 (ru) 1998-02-19 2004-05-27 Эйсай Ко., Лтд. Производные фталазина и терапевтические средства для эректильной дисфункции
FR2816938B1 (fr) 2000-11-22 2003-01-03 Sanofi Synthelabo Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
JP2003246780A (ja) 2001-12-17 2003-09-02 Eisai Co Ltd 含窒素芳香環化合物の製造方法
US6995144B2 (en) 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
FR2843964B1 (fr) * 2002-08-29 2004-10-01 Sanofi Synthelabo Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
EP1558591B1 (en) * 2002-10-07 2014-05-07 The Regents of The University of California Modulation of anxiety through blockade of anandamide hydrolysis
FR2854633B1 (fr) * 2003-05-07 2005-06-24 Sanofi Synthelabo Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
FR2866885B1 (fr) * 2004-02-26 2007-08-31 Sanofi Synthelabo Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique
FR2885364B1 (fr) * 2005-05-03 2007-06-29 Sanofi Aventis Sa Derives d'alkyl-, alkenyl-et alkynylcarbamates, leur preparation et leur application en therapeutique
JP2009544708A (ja) 2006-07-24 2009-12-17 ギリアード サイエンシーズ, インコーポレイテッド ビスフラニルプロテアーゼ阻害剤
TW200831080A (en) * 2006-12-15 2008-08-01 Irm Llc Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2008124085A2 (en) 2007-04-03 2008-10-16 Exelixis, Inc. Methods of using combinations of mek and jak-2 inhibitors
FR2934265B1 (fr) * 2008-07-23 2010-07-30 Sanofi Aventis Derives de carbamates d'alkylthiazoles, leur preparation et leur application en therapeutique
US20100113465A1 (en) * 2008-10-30 2010-05-06 Pfizer Inc. 7-azaspiro[3.5]nonane-7-carboxamide compounds

Similar Documents

Publication Publication Date Title
AU2010215269B2 (en) Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of COPD
US20170128437A1 (en) Amino-quinolines as kinase inhibitors
US20120135997A1 (en) Pharmaceutical composition comprising a lactam or benzenesulfonamide compound
JP2018519323A5 (cg-RX-API-DMAC10.html)
WO2015085238A1 (en) Inhibitors of lpxc
JP2014525432A5 (cg-RX-API-DMAC10.html)
JP2017514830A5 (cg-RX-API-DMAC10.html)
US20050032786A1 (en) 1, 3-benzothiazinone derivatives and use thereof
CA2634676A1 (en) Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp
JP2007524707A5 (cg-RX-API-DMAC10.html)
RU98123074A (ru) Хинолиновые карбоксамиды в качестве ингибиторов фно и фдэ-iv
JP2013510178A5 (cg-RX-API-DMAC10.html)
JP2002030084A5 (cg-RX-API-DMAC10.html)
US20140187592A1 (en) Nitrogen-containing aromatic heterocyclyl compound
JP2019526546A5 (cg-RX-API-DMAC10.html)
JP2021500332A5 (cg-RX-API-DMAC10.html)
JP2020500192A5 (cg-RX-API-DMAC10.html)
JP2008509955A5 (cg-RX-API-DMAC10.html)
JP2007507474A5 (cg-RX-API-DMAC10.html)
WO2002030920A1 (en) Benzimidazole compounds, process for producing the same and use thereof
JP2007522111A5 (cg-RX-API-DMAC10.html)
CN115894367A (zh) 作为补体因子d抑制剂的化合物、其药物组合物和应用
WO2003106429A1 (ja) プロドラッグおよびその製造法
AU2016263311A1 (en) Novel amidoheteroaryl aroyl hydrazide ethynes
JP2005538974A5 (cg-RX-API-DMAC10.html)